Welcome to the Jorgensen Lab

For the past thirty years, the Jorgensen Research Group has been at the forefront of computational chemistry and molecular design. Below is an outline of our progress:

1976-82QM studies of organic ions & ion-molecule complexes
1978- MC for liquids, OPLS force field development
1980- Solvent effects on conformational equilibria
1980-95Development of CAMEO for prediction of products of organic reactions
1983 TIP3P & TIP4P water models
1984 Free-energy profiles for SN2 reactions in solution
1985 1st FEP calculation: CH3CH3 --> CH3OH in water
1985- FEP for reactions in solution (QM + MM), ΔGhyd, ion-pairing, pKas, log P, hydrophobic effects, etc.
1988-96Molecular recognition/organic host-guest complexes
1989 Secondary electrostatic effects for G-C, A-T, etc.
1987- MD and MC for proteins, denaturation, folding, enzymatic rxns
1996- FEP/MC for protein-ligand binding
1997- Full QM/MM for organic & enzymatic reactions
2000- Structure-based drug design, ADME predictions
2001- Semiempirical molecular orbital method development
2003- FEP-guided design and synthesis of enzyme inhibitors

Newest publications

326. Exploiting Structural Analysis, In Silico Screening, and Serendipity to Identify Novel Inhibitors of Drug-Resistant Falciparum Malaria.
Dasgupta, T.; Chitnumsub, P.; Kamchonwongpaisan, S.; Maneeruttanarungroj, C.; Nichols, S. E.; Lyons, T. M.; Tirado-Rives, J.; Jorgensen, W. L.; Yuthavong, Y.; Anderson, K. S.
ACS Chem. Biol. 2009, 4, 29-40. doi:10.1021/cb8002804.

325. Novel Non-Active Site Inhibitor of Cryptosporidium Hominis TS-DHFR Identified by a Virtual Screen.
Martucci, W. E.; Udier-Blagovic, M.; Atreya, C.; Babatunde, O.; Vargo, M. A.; Jorgensen, W. L.; Anderson, K. S.
Bioorg. Med. Chem. Lett. 2009, 19, 418-423. doi:10.1016/j.bmcl.2008.11.054.

324. Origin of the Activity Drop with the E50D Variant of Catalytic Antibody 34E4 for Kemp Elimination.
Alexandrova, A. N; Jorgensen, W. L.
J. Phys. Chem. B 2009, 113, 497-504. doi:10.1021/jp8076084.

323. Discovery of Human Macrophage Migration Inhibitory Factor (MIF)-CD74 Antagonists via Virtual Screening.
Cournia, Z.; Leng, L.; Gandavadi, S.; Du, X.; Bucala, R.; Jorgensen, W. L.
J. Med. Chem. 2009, 52, 416-424. doi:10.1021/jm801100v.

322. Catalytic Mechanism and Performance of Computationally Designed Enzymes for Kemp Elimination.
Alexandrova, A. N.; Rothlisberger, D.; Baker, D.; Jorgensen, W. L.
J. Am. Chem. Soc. 2008, 130, 15907-15915. doi:10.1021/ja804040s.

321. Optimization of Azoles as Anti-Human Immunodeficiency Virus Agents Guided by Free-Energy Calculations.
Zeevaart, J. G.; Wang, L.; Thakur, V. V.; Leung, C. S.; Tirado-Rives, J.; Bailey, C. M.; Domaoal, R. A.; Anderson, K. S.; Jorgensen, W. L.
J. Am. Chem. Soc. 2008, 130, 9492-9499. doi:10.1021/ja8019214.

For more details about the specifics of the research, please see the publications page and the research page.

Group picture Julian Tirado-Rives Patricia Morales de Tirado Joseph Kim Laura Thomas Siegfried Leung Sara Nichols William L. Jorgensen Anastassia Alexandrova Birgit Albrecht Zoe Cournia Vinay Thakur Sunil Grandavadi John Terhorst Krishna Ravindranathan

Group picture